100 related articles for article (PubMed ID: 14681694)
1. Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo.
Qi J; Shackelford R; Manuszak R; Cheng D; Smith M; Link CJ; Wang S
Gene Ther; 2004 Jan; 11(1):25-33. PubMed ID: 14681694
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.
Cortés ML; Bakkenist CJ; Di Maria MV; Kastan MB; Breakefield XO
Gene Ther; 2003 Aug; 10(16):1321-7. PubMed ID: 12883528
[TBL] [Abstract][Full Text] [Related]
3. Expression of human ATM cDNA in Atm-deficient mouse brain mediated by HSV-1 amplicon vector.
Cortés ML; Oehmig A; Perry KF; Sanford JD; Breakefield XO
Neuroscience; 2006 Sep; 141(3):1247-56. PubMed ID: 16809004
[TBL] [Abstract][Full Text] [Related]
4. Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector.
Cortés ML; Oehmig A; Saydam O; Sanford JD; Perry KF; Fraefel C; Breakefield XO
Mol Ther; 2008 Jan; 16(1):81-8. PubMed ID: 17998902
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence imaging after HSV amplicon vector delivery into brain.
Pike L; Petravicz J; Wang S
J Gene Med; 2006 Jul; 8(7):804-13. PubMed ID: 16602134
[TBL] [Abstract][Full Text] [Related]
6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
[TBL] [Abstract][Full Text] [Related]
9. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
10. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
[TBL] [Abstract][Full Text] [Related]
12. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
13. Drug inducible transgene expression in brain using a herpes simplex virus vector.
Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC
Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573
[TBL] [Abstract][Full Text] [Related]
14. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
16. In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors.
Fraefel C; Mendes-Madeira A; Mabon O; Lefebvre A; Le Meur G; Ackermann M; Moullier P; Rolling F
Gene Ther; 2005 Aug; 12(16):1283-8. PubMed ID: 15889134
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
18. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
19. HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells.
Ho IA; Chan KY; Miao L; Shim WS; Guo CM; Cheang P; Hui KM; Lam PY
Cancer Gene Ther; 2008 Sep; 15(9):553-62. PubMed ID: 18535622
[TBL] [Abstract][Full Text] [Related]
20. HIV vector-mediated targeted suicide gene therapy for adult T-cell leukemia.
Miyake K; Inokuchi K; Miyake N; Dan K; Shimada T
Gene Ther; 2007 Dec; 14(23):1662-7. PubMed ID: 17898798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
